LUCCHESI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 5.161
AS - Asia 2.742
EU - Europa 2.091
SA - Sud America 452
AF - Africa 129
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.586
Nazione #
US - Stati Uniti d'America 4.997
SG - Singapore 849
CN - Cina 776
IT - Italia 587
HK - Hong Kong 466
SE - Svezia 408
BR - Brasile 379
VN - Vietnam 243
DE - Germania 211
BG - Bulgaria 176
GB - Regno Unito 153
CA - Canada 131
FR - Francia 118
RU - Federazione Russa 96
TR - Turchia 91
AT - Austria 87
IN - India 65
FI - Finlandia 61
UA - Ucraina 57
JP - Giappone 53
CH - Svizzera 43
KR - Corea 38
IQ - Iraq 30
AR - Argentina 27
CI - Costa d'Avorio 27
ZA - Sudafrica 21
BD - Bangladesh 20
NG - Nigeria 20
NL - Olanda 18
MX - Messico 17
SN - Senegal 17
EG - Egitto 15
PL - Polonia 15
BE - Belgio 14
EC - Ecuador 14
IR - Iran 13
SA - Arabia Saudita 13
ES - Italia 12
CO - Colombia 10
ID - Indonesia 10
MA - Marocco 10
PK - Pakistan 10
UZ - Uzbekistan 10
VE - Venezuela 9
JO - Giordania 8
MY - Malesia 8
GR - Grecia 6
AU - Australia 5
AZ - Azerbaigian 5
BJ - Benin 5
CL - Cile 4
CZ - Repubblica Ceca 4
IL - Israele 4
LT - Lituania 4
PA - Panama 4
RS - Serbia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BY - Bielorussia 3
DZ - Algeria 3
EU - Europa 3
JM - Giamaica 3
KG - Kirghizistan 3
PH - Filippine 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
SY - Repubblica araba siriana 1
Totale 10.583
Città #
Dallas 523
Ashburn 494
Singapore 476
Hong Kong 460
Woodbridge 345
Santa Clara 338
Chandler 317
Ann Arbor 293
Fairfield 283
San Jose 266
Houston 258
Milan 206
Shanghai 178
Sofia 175
Beijing 145
New York 124
Seattle 120
Ottawa 107
Cambridge 105
Wilmington 98
Boardman 90
Serra 86
Princeton 80
Jacksonville 76
Vienna 70
Bremen 66
Los Angeles 64
Ho Chi Minh City 62
Lawrence 62
Lauterbourg 61
Hefei 57
London 52
Medford 51
Chicago 49
Nanjing 43
Tokyo 43
Des Moines 42
Hanoi 40
Istanbul 38
Izmir 36
Pisa 36
Dearborn 34
Manchester 34
Seoul 34
Dong Ket 33
Council Bluffs 31
Bern 30
Frankfurt am Main 29
Marseille 27
Redondo Beach 27
Abidjan 26
São Paulo 24
Buffalo 23
Florence 22
Helsinki 21
Rome 21
Cascina 20
Lagos 19
Redwood City 19
Rio de Janeiro 19
San Diego 18
Shenyang 18
Dakar 17
Boulder 16
Kunming 16
Pune 16
Baghdad 15
Brussels 14
Jüchen 14
Munich 14
Nanchang 14
Orem 14
Jiaxing 13
Nuremberg 13
Turku 13
Chennai 12
Warsaw 12
Zurich 12
Brasília 11
Fuzhou 11
Ogden 11
Tianjin 11
Wuhan 11
Curitiba 10
Boston 9
Changsha 9
Columbus 9
Düsseldorf 9
Hebei 9
San Francisco 9
Tashkent 9
Buenos Aires 8
Haiphong 8
Johannesburg 8
Phoenix 8
The Dalles 8
Belo Horizonte 7
Guangzhou 7
Isfahan 7
Kuala Lumpur 7
Totale 7.465
Nome #
Q192R PARAOXONASE(PON)1 POLYMORPHISM, INSULIN SENSITIVITY AND ENDOTHELIAL FUNCTION IN ESSENTIAL HYPERTENSIVE MEN 291
Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease 283
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 245
Alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria JOURNAL OF HYPERTENSION JUN 2006 VL 24 IS 6 BP 1217 EP 1217 241
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 207
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 207
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 202
ACE gene insertion/deletion polymorphism modulates capillary permeability in hypertension 196
A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells 195
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 194
Grain and bean lysates improve function of endothelial progenitor cells from human peripheral blood: involvement of the endogenous antioxidant defenses. 189
Nutraceuticals and cardiovascular risk: potential role of EPCs modulation 187
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 186
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 180
Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line 175
Cytochrome P450 2J2 polymorphism in healthy Caucasians and those with diabetes mellitus 172
Correlation of endothelial progenitor cells with carbohydrate metabolism in prediabetic and diabetic patients 172
IRS1 G972R missense polymorphism is associated with failure to oral antidiabetes drugs in white patients with type 2 diabetes from Italy 170
SIRT1 rs7896005 polymorphism may be related to coronary artery disease in Caucasians with type 2 diabetes, without affecting all-cause mortality. 170
Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects 165
Influence of severe obesity on circulating endothelial progenitor cells levels and effects of bariatric surgery 165
alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria (vol 24, pg 931, 2006) 164
Human EPCs and HUVECs exposed to high glucose: expression of antioxidative enzymes 163
Efficacy of a resveratrol nanoformulation based on a commercially available liposomal platform 163
Circulating endothelial progenitor cells (EPCs) in subjects with impaired glucose regulation (Pre-Diabetes) 162
Divergent changes in expression of antioxidant enzymes in human EPCs and HUVECs exposed to high glucose 158
Probiotic Lisosan G preserves functional properties of human endo- thelial progenitor cells exposed to lipopolysaccharides 157
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 157
A fermented bean flour extract downregulates LOX-1, CHOP and ICAM-1 in HMEC-1 stimulated by ox-LDL 152
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 151
Endothelial progenitor cells in subjects with pre-diabetes 150
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study 148
The association of alpha-1 adducin and ace polymorphisms with microalbuminuria in hypertensive men 147
Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells. Evidence for differential responses 147
Circulating endothelial progenitor cells in women with gestational alterations of glucose tolerance 147
Clearance plasmatica dello iohexolo per la misurazione del filtrato glomerulare nel paziente con diabete mellito: studio per un approccio semplificato 143
Divergent changes in expression of antioxidant enzymes in human EPCs and HUVECs exposed to high glucose 141
Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals 140
Lack of association between CYP21 V281L variant and polycystic ovary syndrome in Italian women 139
Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria, and endothelial dysfunction in hypertensive men 138
Cystatin C and estimates of renal function: Searching for a better measure of kidney function in diabetic patients 137
alpha-Adducin and angiotensin-converting enzyme polymorphisms in hypertension: evidence for a joint influence on albuminuria 129
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study. diabetes care 2020;43:E139–e141 129
Spot-Synthesis: Easy Multiple Preparation of Synthetic Peptides on Cellulose Membrane for the Analysis of Anti-Protein Antibodies 128
Heterogeneity of chronic kidney disease (CKD) phenothypes in patients with type 1 diabetes mellitus 128
Influence of HDL cholesterol levels on endothelial progenitor cells function in patients with type 2 diabetes mellitus 125
Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells. Evidence for differential glutathione peroxidase-1 expression 123
SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all-cause mortality, in Caucasians with type 2 diabetes: A 13-year observational study 122
The IRS1 G972R polymorphism and glomerular filtration rate in patients with type 2 diabetes of European ancestry 122
Soluble CD40 ligand levels in essential hypertensive men: evidence of a possible role of insulin resistance 121
INTEGRIN BETA 3 PLA1/PLA2 POLIMORPHISM DOES NOT CONTRIBUTE TO COMPLICATIONS IN BOTH TYPE 1 AND TYPE 2 DIABETES 121
Antibody Specificity analyzed by Peptides synthesized on Cellulose Membranes 119
Trattamento intensivo dell’ipertensione arteriosa nel paziente diabetico: evidenze epidemiologiche e cliniche 116
Lack of association between TGF-ß-1 genotypes and microalbuminuria in essential hypertensive men 115
Effects of pioglitazone versus glyburide on endothelial function in type 2 diabetic patients with vascular complications: the SPLENDOR Study 114
The rs12917707 polymorphism at the UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: Evidence of heterogeneity across two different European populations 109
The 9p21 coronary artery disease locus and kidney dysfunction in patients with Type 2 diabetes mellitus 107
An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY? 105
Ipertensione arteriosa e rischio cardiovascolare 98
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes 97
Eterogeneità di malattia renale cronica (CKD) nel diabete mellito tipo 1 (DMT1) 97
Effetti antiossidanti ed epatoprotettivi del lisato di grano 97
I biomarcatori nella prevenzione cardiovascolare: considerazioni pratiche 94
The metabolic syndrome. An inflammation hypothesis 91
Epidemiologia della nefropatia nel diabete mellito 85
La microalbuminuria: cosa si aspetta il clinico 81
La proteinuria nel diabete: epidemiologia, progressione verso l’insufficienza renale, comorbidità e potenzialità del trattamento antipertensivo 80
Integrazione di albuminuria e filtrato glomerulare (GFR) nella Stadiazione della Nefropatia Diabetica 77
La terapia antiaggregante nella prevenzione cardiovascolare tra vecchi e nuovi farmaci 77
Inclusione di un estratto di farina di grano fermentata in liposomi per la somministrazione orale: effetto su cellule intestinali HT-29 70
Pumpkin seed proteins (Cucurbita pepo L.) protect against diet-induced metabolic syndrome by improving insulin resistance and markers of oxidative stress and inflammation in rats 64
Tackling the challenges of the oral administration of a fermented flour extract with liposomes: Effect on intestinal HT-29 cells 63
null 61
Diagnostica di laboratorio: esami su urine. Gli esami per il diabete 58
Liposomal Formulations to Improve Antioxidant Power of Myrtle Berry Extract for Potential Skin Application 54
null 46
null 44
null 21
null 13
Totale 10.697
Categoria #
all - tutte 30.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 31 80
2021/2022760 9 51 16 50 152 91 26 36 39 14 56 220
2022/20231.144 137 167 89 142 122 133 18 96 173 4 54 9
2023/2024889 106 101 102 50 131 143 39 24 16 24 36 117
2024/20252.400 19 80 34 130 228 296 242 146 235 305 230 455
2025/20262.861 172 391 553 289 270 214 373 104 183 257 55 0
Totale 10.697